The global non-Hodgkin lymphoma treatment market size is projected to reach USD 12.57 billion by the end of 2026. The increasing number of regulatory approvals will aid the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Non-Hodgkin Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (B-cell Lymphoma, and T-cell Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), and Regional Forecast, 2019-2026,” the market was worth USD 6.60 billion in 2018 and will exhibit a CAGR of 8.4% during the forecast period.
Highlights of the Report:
- In-depth analysis of various insights, namely, Non-Hodgkin Lymphoma Treatment Market trends, growth drivers, opportunities, and other related challenges.
- Comprehensive details of key market players, their core competencies, and Non-Hodgkin Lymphoma Treatment Market share.
- The potency of suppliers and buyers to make better business decisions.
- Lists out the market size in terms of volume
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/non-hodgkin-lymphoma-treatment-market-102642
Key Players Operating in The Non-Hodgkin Lymphoma Treatment Market Include:
Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are
- Takeda Pharmaceutical Company Limited
- AstraZeneca
- Bayer AG
- Novartis AG
- Kite Pharma, Inc. / Gilead Sciences, Inc.
- Spectrum Pharmaceuticals, Inc.
- Teva Pharmaceutical Industries Ltd.
- Bristol Myers Squibb Company
- Janssen Pharmaceuticals, Inc.
- Genentech, Inc. (F. Hoffmann-La Roche Ltd)
- CELGENE CORPORATION (Bristol Myers Squibb Company)
- Merck & Co., Inc.
- Kyowa Kirin Co., Ltd.
- AbbVie Inc.
- Sanofi
- Others
Increasing Number of Regulatory Approvals Will Aid Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. Among all factors, the increasing number of regulatory approvals has made a huge impact on the growth of the overall market. In October 2017, AstraZeneca announced that it has received approval from the US Food and Drug Administration (FDA) for its latest treatment option for non-Hodgkin lymphoma. The company announced that ‘Calquence’ was cleared for use in treatment of patients suffering from the disease. The company looks to build on its previous steps taken to establish a stronghold in the market. This product will not just help the company grow, but will also have a positive impact on the growth of the market in the forthcoming years.
North America to Emerge Dominant; Increasing Adoption of Automated Products Will Aid Growth
The report analyzes the ongoing non-Hodgkin lymphoma treatment market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in North America held the largest market share in 2018. The efforts put in by large scale companies towards the development of efficient treatment options associated with the disease will aid the growth of the regional market. Moreover, the high prevalence of the disease in this region will also contribute to market growth. As of 2018, the market in North America was worth USD 3.16 billion and this value is projected to increase further in the coming years. The market in Europe and Asia Pacific will also witness considerable growth in the coming years, driven by the improving healthcare reimbursement policies in several countries across this region.
Detailed Table of Content:
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Key Insights
- Prevalence of Lymphoma – by Key Countries – 2018
- Pipeline Analysis
- Key Industry Developments
- Regulatory Scenario, by Key Regions
- Analysis of Economic Burden of Non-Hodgkin Lymphoma
- New Product Launches
- Overview of Emerging Treatments for Non-Hodgkin Lymphoma
- Global Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis, Insights and Forecast – By Therapy
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Others
- Market Analysis, Insights and Forecast – By Disease Type
- B-cell Lymphoma
- T-cell Lymphoma
- Market Analysis, Insights and Forecast – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- North America Non-Hodgkin Lymphoma Treatment Market Analysis, Insights and Forecast, 2015-2026
- Key Findings / Summary
- Market Analysis – By Therapy
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Others
- Market Analysis – By Disease Type
- B-cell Lymphoma
- T-cell Lymphoma
- Market Analysis – By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies & Drug Stores
- Online Pharmacies
- Market Analysis – By Country
- S.
- Canada
TOC Continued….
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/non-hodgkin-lymphoma-treatment-market-102642
Report Focus:
- Extensive product offerings
- Customer research services
- Robust research methodology
- Comprehensive reports
- Latest technological developments
- Value chain analysis
- Potential Non-Hodgkin Lymphoma Treatment Market opportunities
- Growth dynamics
- Quality assurance
- Post-sales support
- Regular report update
Reasons to Purchase this Report:
- Comprehensive analysis of the Non-Hodgkin Lymphoma Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
- Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
- Identifies market restraints and boosters.
- Identifies all the possible segments present in the market to aid organizations in strategic business planning.
KEY QUESTIONS ANSWERED:
- What is the market size and growth rate of the global and regional market by various segments?
- What is the market size and growth rate of the market for selective countries?
- Which region or sub-segment is expected to drive the market in the forecast period?
- What Factors are estimated to drive and restrain the Non-Hodgkin Lymphoma Treatment Market growth?
- What are the key technological and market trends shaping the market?
- What are the key opportunities in the market?
- What are the key companies operating in the market?
- Which company accounted for the highest market share
